Quest Diagnostics (DGX) Other Non-Current Liabilities (2009 - 2026)

Quest Diagnostics has reported Other Non-Current Liabilities for 18 years, with the latest figure at $1.1 billion in Q2 2026.

• Quarterly Other Non-Current Liabilities rose 18.99% year-over-year to $1.1 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.1 billion (up 18.99% YoY) and the FY2025 annual result came in at $957.0 million, up 2.03% from the prior year.
• Other Non-Current Liabilities climbed to $1.1 billion in Q2 2026 per DGX's latest filing, from $1.0 billion in the prior quarter.
• Over five years, Other Non-Current Liabilities peaked at $1.1 billion in Q2 2026 and troughed at $6.0 million in Q2 2024.
• A 5-year average of $788.6 million and a median of $875.0 million in 2023 frame the typical range for Other Non-Current Liabilities.
• The sharpest annual moves came in 2024 and 2025: Other Non-Current Liabilities slumped 93.18% in 2024, then surged 14733.33% in 2025.
• Over 5 years, Other Non-Current Liabilities stood at $812.0 million in 2022, then increased by 7.88% to $876.0 million in 2023, then gained by 7.08% to $938.0 million in 2024, then climbed by 2.03% to $957.0 million in 2025, then increased by 10.66% to $1.1 billion in 2026.
• According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $1.1 billion, $1.0 billion, and $957.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.